Is Welcure Drugs And Pharmaceutic a good stock to invest in?

Welcure Drugs And Pharmaceutic can be analyzed on the following key metrics - TTM P/E: 8.38 Sector P/E: 24.5 Dividend Yield: 0% D/E ratio: -

Welcure Drugs And Pharmaceutic Share Price

Sector: Major Drugs

Powered by

11.44 -0.27 (-2.31%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 11.13

Today’s High 11.71

52 Week Low 4.30

52 Week High 15.81

Key Metrics

Market Cap (In Cr) 128.27
Beta 0.77
Div. Yield (%) 0
P/B 11.8
TTM P/E 8.38
Peg Ratio -
Sector P/E 24.5
Open Price 11.35
Prev Close 11.71

View All Metrics

Welcure Drugs And Pharmaceutic Analysis

Price Analysis

1 Week

10.06%
3 Months

26.46%
6 Month

45.11%
YTD

0.34%
1 Year

138.49%

Risk Meter

60% Low risk
60% Moderate risk
60% Balanced Risk
60% High risk
60% Extreme risk

Welcure Drugs And Pharmaceutic Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2024

Total Revenue
0

Selling/ General/ Admin Expenses Total
0.09

Depreciation/ Amortization
0.04

Other Operating Expenses Total
0.15

Total Operating Expense
0.27

Operating Income
-0.27

Net Income Before Taxes
-0.17

Net Income
-0.17

Diluted Normalized EPS
-0.13

Period
2023

Total Revenue
0

Selling/ General/ Admin Expenses Total
0.01

Other Operating Expenses Total
0.11

Total Operating Expense
0.12

Operating Income
-0.12

Net Income Before Taxes
-0.05

Net Income
-0.05

Diluted Normalized EPS
0

Period
2022

Total Revenue
0.11

Selling/ General/ Admin Expenses Total
0.08

Other Operating Expenses Total
0

Total Operating Expense
0.08

Operating Income
0.02

Net Income Before Taxes
0.02

Net Income
0.02

Diluted Normalized EPS
0.02

Period
2021

Total Revenue
0.13

Selling/ General/ Admin Expenses Total
0.08

Other Operating Expenses Total
0

Total Operating Expense
0.08

Operating Income
0.05

Net Income Before Taxes
0.06

Net Income
0.06

Diluted Normalized EPS
0.05

Period
2020

Total Revenue
0.08

Selling/ General/ Admin Expenses Total
0.09

Other Operating Expenses Total
0

Total Operating Expense
0.09

Operating Income
-0.01

Net Income Before Taxes
-0.01

Net Income
-0.01

Diluted Normalized EPS
-0.01

Period
2019

Total Revenue
0.08

Selling/ General/ Admin Expenses Total
0.07

Other Operating Expenses Total
0.01

Total Operating Expense
0.08

Operating Income
0

Net Income Before Taxes
0

Net Income
0

Diluted Normalized EPS
0

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Welcure Drugs And Pharmaceutic Technical

Moving Average SMA

5 Day11.32
10 Day10.55
20 Day9.5

50 Day8.97
100 Day9.73
300 Day9.41

Welcure Drugs And Pharmaceutic Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Ambalal Sarabhai Enterprises
38.93
-0.35
-0.89
77.7
34.11
298.73

Pharmaids Pharmaceuticals
67.95
1.08
1.62
87.46
31.9
239.22

Welcure Drugs And Pharmaceutic
11.44
-0.27
-2.31
15.81
4.3
128.27

Bharat Immunologica And Bio Corp
24.36
0.98
4.19
35.88
19
105.91

Makers Laboratories
165.35
27.3
19.78
230
114
97.59

Welcure Drugs And Pharmaceutic Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

14-May-25
Others

14-Feb-25
Quarterly Results

14-Nov-24
Quarterly Results

13-Nov-24
Quarterly Results

21-Oct-24
Others

14-Aug-24
Quarterly Results

10-Jun-24
Others

30-May-24
Audited Results

28-Mar-24
Others

14-Feb-24
Quarterly Results

Meeting Date
Announced on
Purpose

16-Jun-25
15-May-25
POM

24-Feb-25
23-Jan-25
POM

04-Jan-25
03-Dec-24
POM

30-Sept-24
09-Sept-24
AGM

13-Jul-24
11-Jun-24
POM

28-Sept-23
20-Sept-23
AGM

27-Jun-22
26-May-22
AGM

12-Jul-21
26-May-21
AGM

View All

Company Profile

ABOUT Welcure Drugs And Pharmaceutic

Industry Major Drugs
ISIN INE331C01017
BSE Code 524661

Welcure Drugs and Pharmaceuticals Limited is an India-based company. The Company operates in one segment, which is the Manufacturing of Steel, Non-Alloys Steel and Alloys Steel Casting.

MANAGEMENT

Altaf Shah Chief Financial Officer, Managing Director

WELCURE DRUGS AND PHARMACEUTIC SUMMARY

Welcure Drugs And Pharmaceutic is trading 2.31% lower at Rs 11.44 as compared to its last closing price. Welcure Drugs And Pharmaceutic has been trading in the price range of 11.71 & 11.13. Welcure Drugs And Pharmaceutic has given 0.34% in this year & 10.06% in the last 5 days.

Welcure Drugs And Pharmaceutic has TTM P/E ratio 8.38 as compared to the sector P/E of 24.5.

The company posted a net profit of 0.41 Crores in its last quarter.

Listed peers of Welcure Drugs And Pharmaceutic include Ambalal Sarabhai Enterprises (-0.89%), Pharmaids Pharmaceuticals (1.62%), Welcure Drugs And Pharmaceutic (-2.31%) etc.

Welcure Drugs And Pharmaceutic has a 100% public holding.

FAQs about Welcure Drugs And Pharmaceutic

Welcure Drugs And Pharmaceutic is trading at 11.44 as on 19 May, 2025 3:29:38 PM. This is -2.31% lower as compared to its previous closing price of 11.71

The market capitalization of Welcure Drugs And Pharmaceutic is 128.27 Cr as on 19 May, 2025 3:29:38 PM.

The 52 wk high for Welcure Drugs And Pharmaceutic is 15.81 whereas the 52 wk low is 4.30

Welcure Drugs And Pharmaceutic can be analyzed on the following key metrics -

TTM P/E: 8.38
Sector P/E: 24.5
Dividend Yield: 0%
D/E ratio: -

Welcure Drugs And Pharmaceutic reported a net profit of -0.17 Cr in 2024.

Welcure Drugs And Pharmaceutic Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Welcure Drugs And Pharmaceutic Share Price

Price Range

Key Metrics

Welcure Drugs And Pharmaceutic Analysis

Welcure Drugs And Pharmaceutic Financials

Forecast

Forecast

Forecast

Welcure Drugs And Pharmaceutic Technical

Welcure Drugs And Pharmaceutic Peers

Welcure Drugs And Pharmaceutic Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Welcure Drugs And Pharmaceutic

MANAGEMENT

WELCURE DRUGS AND PHARMACEUTIC SUMMARY

FAQs about Welcure Drugs And Pharmaceutic

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue